FDA’s new voluntary pilot program is designed to help clinicians select appropriate cancer treatments for patients.
Grant Playter
Advertisement
Grant Playter is Associate Editor for Pharmaceutical Technology, BioPharm International, and Pharmaceutical Technology Europe.
Articles by Grant Playter
Advertisement
Latest Updated Articles
FDA Launches Pilot Program Using Cancer Biomarkers to Mitigate RiskPublished: June 21st 2023 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Reimagining Clinical Operations Through Artificial Intelligence
2
Integrating AI Across Legacy Clinical Trial Systems
3
Preparation Tips to Minimize Impact of Regulatory Inspections for IRT Systems
4
Balancing Human Oversight and Automation in AI-Driven Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
